Clinical Trials Logo

Contact Lens Dryness clinical trials

View clinical trials related to Contact Lens Dryness.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03686878 Completed - Clinical trials for Contact Lens Discomfort

Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness

Start date: December 16, 2016
Phase: Phase 4
Study type: Interventional

The most common reason for contact lens discontinuation is contact lens discomfort. The investigators believe that inflammation plays a role in contact lens discomfort and the use of lifitegrast 5% ophthalmic solution may reduce end of the day contact lens discomfort. This study will enroll 21 contact lens users who will be receiving lifitegrast 5% ophthalmic solution and monitor the contact lens discomfort for a 8 week period while.